Leishmania major peptide-MHC class II complex (L. major pMHCII)

The Leishmania major peptide-MHC class II complex is a critical immunological assembly formed on the surface of host antigen-presenting cells (APCs), such as macrophages and dendritic cells, during infection with the protozoan parasite Leishmania major (Kaye & Scott, 2011). This complex consists of parasite-derived antigenic peptides, such as the Leishmania homolog of receptors for activated C kinase (LACK) or the surface protease gp63, non-covalently bound within the peptide-binding groove of a host Major Histocompatibility Complex (MHC) class II molecule (Mougneau et al., 1995). The primary biological role of this complex is to serve as the ligand for the T-cell receptor (TCR) on CD4+ T-helper cells, a process essential for the initiation of an adaptive immune response (Scott & Hunter, 2002). Successful recognition of the pMHCII complex typically triggers a Th1-type response, leading to the secretion of interferon-gamma (IFN-gamma) and subsequent macrophage activation to eliminate intracellular amastigotes. In therapeutic development, this complex is the primary target for subunit vaccines and immunotherapies, such as the Leish-F1 fusion protein, aimed at inducing protective cellular immunity against cutaneous leishmaniasis (Coler & Reed, 2005). However, the parasite has evolved mechanisms to interfere with the formation and stability of these complexes to evade the host immune system, presenting a significant challenge for drug and vaccine efficacy (Kaye & Scott, 2011).

Other names

Leishmania major antigen-MHC II complexL. major pMHCIILeishmania major peptide-HLA class II complexLACK-MHC II complexgp63-MHC II complexLeishmania major antigenic peptides bound to MHC class II

The complex acts as a ligand for the T-cell receptor (TCR) on CD4+ T cells, initiating a signaling cascade that leads to Th1 differentiation and the release of pro-inflammatory cytokines like IFN-gamma, which activates macrophages to kill Leishmania amastigotes (Scott & Hunter, 2002; Kaye & Scott, 2011).